Long Term Rectal Toxicity and Rectal Bleeding Following Cs-131 Prostate Brachytherapy

Major rectal bleeding following transrectal needle prostate biopsy.

Nomogram to predict rectal toxicity following prostate cancer radiotherapy

BACKGROUND To identify predictors of acute and late rectal toxicity following prostate cancer radiotherapy (RT), while integrating the potential impact of RT technique, dose escalation, and moderate hypofractionation, thus enabling us to generate a nomogram for individual prediction. METHODS In total, 972 patients underwent RT for localized prostate cancer, to a total dose of 70 Gy or 80 Gy, ...

The effect of Rectal Retractor, a rectal protector on rectal dose in radical prostate radiotherapy

Introduction: The close proximity of the rectum tissue to the prostate gland results in rectal toxicity during prostate radiotherapy. Rectal Retractor (RR) is a rectal displacement technique that inserts into the rectum, as a result, the lateral and dorsal part of the rectal wall push away from high dose areas. The aim of this study was to investigate the dosimetric consequence...

Fatal Rectal Bleeding after Prostate Biopsy

Transrectal ultrasound (TRUS)-guided biopsy of the prostate is a gold-standard for diagnosing the prostatic cancer. It is a relatively less invasive technique and known to be fast, safe, and effective method, because post biopsy complications including gross hematuria, rectal bleeding, hematospermia, fever and chill are mostly self-limiting and the rate of major complications are low. Rare majo...

Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancer

The purpose of this study was to determine the risk factors for rectal bleeding after prostate brachytherapy. Between April 2005 and September 2009, 89 patients with T1c-2cN0M0 prostate cancer were treated with permanent I-125 seed implantation alone. The prostate prescription dose was 145 Gy, and the grade of rectal bleeding was scored according to the Common Terminology Criteria for Adverse E...